Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Moderna's Next $20B Franchise - Learning From Merck's Keytruda
04:00pm, Friday, 16'th Dec 2022
Keytruda has proved to be MRK's leading sales driver, projected to contribute a significant 35.38% of FY2022 revenues at $20.9B. Given the early clinical success of MRNA and Keytruda combo, we reckon
JPMorgan's bullish call on biopharma
02:12pm, Friday, 16'th Dec 2022
The "Halftime Report" traders debate the biggest analyst calls of the day.
4 Drug Stocks Up More Than 40% YTD With Room to Grow in 2023
09:47am, Friday, 16'th Dec 2022
Here are four drug companies, MRK, VRTX, IMCR and IMVT, that are up 40% or more in 2022 so far and still have room for growth in 2023.
2 Dividend Stocks to Buy and Hold Through 2023 and Beyond
08:30am, Thursday, 15'th Dec 2022
These pharma giants are crushing the broader market this year.
4 Large Drug Stocks to Watch in a Booming Industry
09:47am, Wednesday, 14'th Dec 2022
Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, Johnson & Johnson (JNJ), Novo Nordisk (NVO), Merck (MRK) and AstraZeneca
Moderna, Merck stocks boosted amid joint cancer vaccine trials
04:52pm, Tuesday, 13'th Dec 2022
Yahoo Finance health correspondent Anjalee Khemlani joins the Live show to review Moderna and Merck shares following positive results seen in their joint cancer vaccine trial.
Moderna shares get a boost from Merck vaccine combo
12:49pm, Tuesday, 13'th Dec 2022
Moderna Therapeutics Inc (NASDAQ:MRNA) shares rallied after the biotechnology firm told investors that a trial that combined its investigational cancer vaccine with drug giant Merck & Co Inc (NYSE:MRK
Trending Today: 5 Stocks in the News
12:48pm, Tuesday, 13'th Dec 2022
So far this week, several stocks have had headline-driven catalysts. We will cover 5 stocks trending in the news.
Moderna and Merck team-up to fight melanoma
10:49am, Tuesday, 13'th Dec 2022
Vaccine-maker Moderna has partnered with the biopharmaceutical company Merck to create an effective treatment for skin cancer
Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now?
10:32am, Tuesday, 13'th Dec 2022
Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Merck, Moderna say mRNA vaccine and Keytruda lowers the risk of death in melanoma patients
07:34am, Tuesday, 13'th Dec 2022
Merck & Co. Inc. MRK, +0.17% and Moderna Inc. MRNA, -6.89% said Tuesday that their experimental mRNA-based cancer vaccine reduced the risk of recurrence or death when used with Merck's Keytruda in pat
Why Merck's $250 Million Investment In Moderna May Have Just Paid Off
07:00am, Tuesday, 13'th Dec 2022
Moderna unveiled promising results for its personalized cancer vaccine on Tuesday. The results could spark downtrodden Moderna stock.
3 Non-Energy S&P 500 Stocks With Enough Energy to Boost Returns
09:47am, Monday, 12'th Dec 2022
Though energy companies have been among the best-performing stocks in the S&P 500 index, here we discuss some top-performing non-energy S&P 500 stocks like MRK, VRTX and MCK.
3 High-Flying Stocks in 2022 That Should Keep Soaring in 2023
06:10am, Saturday, 10'th Dec 2022
These stocks' tailwinds should continue blowing in the new year.
Early Q4 Earnings Results and Analyst Reports for Merck, Bristol-Myers & Deere
03:03pm, Friday, 09'th Dec 2022
Today's Research Daily features update on the Q4 earnings season and new research reports on Merck (MRK), Bristol-Myers (BMY) and Deere (DE).
